Soleno Therapeutics, Inc. - Common Stock (NQ:SLNO)

52.56 +0.05 (+0.10%)

Streaming Delayed Price Updated: 2:47 PM EDT, Apr 10, 2026 Add to My Watchlist

Price and Volume

Volume	2,376,541
Open	52.50
Bid (Size)	52.56 (2,800)
Ask (Size)	52.57 (2,700)
Prev. Close	52.51
Today's Range	52.48 - 52.58
52wk Range	29.43 - 90.32
Shares Outstanding	8,168,788
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Soleno Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – SLNO

April 09, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

SOLENO LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Soleno Therapeutics, Inc. and Encourages Investors to Contact the Firm

April 09, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

Performance

YTD	+11.4%	+11.4%
1 Month	+29.4%	+29.4%
3 Month	+15.5%	+15.5%
6 Month	-19.8%	-19.8%
1 Year	-16.9%	-16.9%

More News

Soleno Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Soleno Therapeutics, Inc. - SLNO

April 09, 2026

From SkyMedia, LLC

Via GlobeNewswire

SOLENO THERAPEUTICS, INC. (SLNO) DEADLINE ALERT Bernstein Liebhard LLP Reminds Soleno Therapeutics, Inc. Investors of Upcoming Deadline

April 09, 2026

From Bernstein Liebhard LLP

Via GlobeNewswire

Soleno Therapeutics, Inc. Notice of May 5, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

April 07, 2026

From Kahn Swick & Foti, LLC

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Soleno Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – SLNO

April 07, 2026

From Pomerantz LLP

Via GlobeNewswire

SLNO Investor Alert: Soleno Therapeutics, Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Company Allegedly Concealed Commercial Viability Risks: Levi & Korsinsky

April 07, 2026

From Levi & Korsinsky, LLP

Via Business Wire

Neurocrine Biosciences to Acquire Celeno Therapeutics in Rare Disease Deal

April 07, 2026

Via MarketMinute

Halper Sadeh LLC is Investigating Whether SLNO, FORA, MKC, CYCN are Obtaining Fair Deals for their Shareholders

April 07, 2026

From Halper Sadeh LLC

Via GlobeNewswire

Soleno Therapeutics: A Masterclass in Rare Disease Redemption and the $2.9B Exit

April 07, 2026

Via Finterra

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Soleno Therapeutics, Inc. (SLNO)

April 07, 2026

From Bernstein Liebhard LLP

Via GlobeNewswire

Wall Street Holds Its Ground While Trump's Iran Deadline Ticks Down ↗

April 07, 2026

Via Chartmill

Stock Market Today, April 6: Soleno Therapeutics Climbs After $2.9 Billion All-Cash Buyout Agreement ↗

April 06, 2026

Via The Motley Fool

Why Soleno Therapeutics Stock Rocketed Higher on Monday ↗

April 06, 2026

Via The Motley Fool

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Soleno Therapeutics, Inc. (Nasdaq – SLNO), Affinity Bancshares, Forian, Inc. (Nasdaq – FORA), Janus Henderson Group plc (NYSE - JHG)

April 06, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

Monday's session: top gainers and losers ↗

April 06, 2026

Via Chartmill

Neurocrine Biosciences to Acquire Soleno Therapeutics in $2.9 Billion Deal as VYKAT™ XR Sales Soar

April 06, 2026

Via MarketMinute

Which stocks are moving on Monday? ↗

April 06, 2026

Via Chartmill

SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

April 06, 2026

From Schall Law

Via GlobeNewswire

Monday's session: gap up and gap down stocks ↗

April 06, 2026

Via Chartmill

SLNO Stock Alert: Halper Sadeh LLC is Investigating Whether Soleno Therapeutics, Inc. is Obtaining a Fair Price for its Shareholders

April 06, 2026

From Halper Sadeh LLC

Via Business Wire

Stay updated with the stocks that are on the move in today's pre-market session. ↗

April 06, 2026

Via Chartmill

Why Applied Optoelectronics Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket ↗

April 06, 2026

Via Benzinga

SLNO Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages SLNO Investors With Losses to Contact the Firm

April 04, 2026

Via TheNewswire.com

SLNO Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages SLNO Investors With Losses to Contact the Firm

April 04, 2026

Via NewMediaWire

Frequently Asked Questions

Is Soleno Therapeutics, Inc. - Common Stock publicly traded?

Yes, Soleno Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Soleno Therapeutics, Inc. - Common Stock trade on?

Soleno Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Soleno Therapeutics, Inc. - Common Stock?

The ticker symbol for Soleno Therapeutics, Inc. - Common Stock is SLNO on the Nasdaq Stock Market

What is the current price of Soleno Therapeutics, Inc. - Common Stock?

The current price of Soleno Therapeutics, Inc. - Common Stock is 52.56

When was Soleno Therapeutics, Inc. - Common Stock last traded?

The last trade of Soleno Therapeutics, Inc. - Common Stock was at 04/10/26 02:47 PM ET

What is the market capitalization of Soleno Therapeutics, Inc. - Common Stock?

The market capitalization of Soleno Therapeutics, Inc. - Common Stock is 429.39M

How many shares of Soleno Therapeutics, Inc. - Common Stock are outstanding?

Soleno Therapeutics, Inc. - Common Stock has 429M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.